Managing Breakthrough Fungal Infections in Hematologic Patients: Determinants and Practical Management from a Latin American Perspective on Behalf of INFOCUS LATAM–ISHAM Working Group

spp. Early clinical recognition, rapid therapy escalation, aggressive diagnostic investigation, a switch to liposomal amphotericin B-based regimens in patients on azole prophylaxis, and therapeutic drug monitoring are essential to improve outcomes. Reducing the growing global burden of bIFIs will also require improved access to high-quality diagnostics and strengthened educational and stewardship efforts that prioritize antifungal resistance as an urgent health concern.

Authors

Institutions

Publication Details

Journal
Microorganisms
Published
2026-04-16
DOI
https://doi.org/10.3390/microorganisms14040904
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Managing Breakthrough Fungal Infections in Hematologic Patients: Determinants and Practical Management from a Latin American Perspective on Behalf of INFOCUS LATAM–ISHAM Working Group

Márcio Nucci, Daniel Aguilar-Zapata, Pablo Andrés Moncada, Arnaldo Lopes Colombo et al.
Microorganisms
Antifungal resistance and susceptibility
article

Managing Breakthrough Fungal Infections in Hematologic Patients: Determinants and Practical Management from a Latin American Perspective on Behalf of INFOCUS LATAM–ISHAM Working Group

Márcio Nucci, Daniel Aguilar-Zapata, Pablo Andrés Moncada, Arnaldo Lopes Colombo, Giovanni Luís Breda, Ricardo Rabagliati, Larissa Simão Gandolpho, Fernando Riera, Mariana Guaraná
article en

Abstract

spp. Early clinical recognition, rapid therapy escalation, aggressive diagnostic investigation, a switch to liposomal amphotericin B-based regimens in patients on azole prophylaxis, and therapeutic drug monitoring are essential to improve outcomes. Reducing the growing global burden of bIFIs will also require improved access to high-quality diagnostics and strengthened educational and stewardship efforts that prioritize antifungal resistance as an urgent health concern.

MicroorganismsVol. 14(4)
Universidade Federal do Rio de Janeiro (BR), Pontificia Universidad Católica de Chile (CL), Universidad Nacional de Córdoba (AR), Hospital General de México (MX), Universidade Nove de Julho (BR), Instituto de Salud Pública de Chile (CL), Hospital Universitário Gaffrée e Guinle (BR), Fundación Valle del Lili (CO), Centro Científico Tecnológico - Córdoba (AR), CNR de la Résistance aux Antibiotiques (FR), Hospital de Clínicas Universidade Federal do Paraná (BR), Sociedade Brasileira de Oncologia Clínica (BR), Fundacion Allende (AR), Universidade Federal do Estado do Rio de Janeiro (BR), Universidade Federal de São Paulo (BR)
Fundação de Amparo à Pesquisa do Estado de São Paulo
Openalex Percentile: Top 19%
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.